Traws Pharma grants COO options for 93,000 shares
Traws Pharma, Inc. reported that Chief Operating Officer Nikolay Savchuk received a grant of stock options covering 93,000 shares of common stock on July 9, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Traws Pharma, Inc. reported that Chief Operating Officer Nikolay Savchuk received a grant of stock options covering 93,000 shares of common stock on July 9, 2026. The options have an exercise price of $0.68 per share, expire on July 9, 2036, and vest 100% on the first anniversary of the grant date.
Insider Trade Summary
Grant/Award: 93,000 shares
Grant/Award
1 txn
Insider
Savchuk Nikolay
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 93,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 93,000 contracts (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 93,000 contracts (Direct)
Footnotes (1)
- F1. Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.
Key Figures
Options Granted: 93,000 shares
Exercise Price: $0.68 per share
Expiration Date: July 9, 2036
+2 more
5 metrics
Options Granted
93,000 shares
Stock options covering 93,000 shares of common stock granted to COO on July 9, 2026
Exercise Price
$0.68 per share
Exercise price of stock options granted to COO under 2021 Incentive Compensation Plan
Expiration Date
July 9, 2036
Expiration date of the 93,000 stock options granted to COO
Vesting Portion
100%
Options vest 100% on the first anniversary of the July 9, 2026 grant date
Post-transaction Options Held
93,000 options
Total derivative securities held directly by COO following the grant
Key Terms
Stock Option, Incentive Compensation Plan, exercise price, vest 100%, +1 more
5 terms
Stock Option financial
"Represents stock options awarded by the Issuer's compensation committee"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Incentive Compensation Plan financial
"under the Issuer's 2021 Incentive Compensation Plan, as amended"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
exercise price financial
"conversion_or_exercise_price: "0.6800" for the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest 100% financial
"The stock options under this award will vest 100% on the first anniversary"
expiration date financial
"expiration_date: "2036-07-09" for the granted stock options"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Traws Pharma (TRAW) disclose for Nikolay Savchuk?
Traws Pharma disclosed that COO Nikolay Savchuk received a grant of 93,000 stock options on July 9, 2026. These options relate to the company’s common stock and were awarded as part of the 2021 Incentive Compensation Plan.
What is the exercise price of the stock options granted to the TRAW COO?
The stock options granted to COO Nikolay Savchuk carry an exercise price of $0.68 per share. This is the price at which he may purchase Traws Pharma common shares when the options become exercisable.
When do Nikolay Savchuk’s Traws Pharma (TRAW) stock options vest?
The stock options awarded to COO Nikolay Savchuk will vest 100% on the first anniversary of the July 9, 2026 grant date. Full vesting means all 93,000 optioned shares become eligible for potential exercise at that time.
What is the expiration date of the Traws Pharma (TRAW) options granted to the COO?
The stock options granted to COO Nikolay Savchuk expire on July 9, 2036. After that date, any unexercised portion of the 93,000 options will lapse and can no longer be used to purchase Traws Pharma common shares.
How many Traws Pharma (TRAW) options does the COO hold after this grant?
Following this award, COO Nikolay Savchuk holds 93,000 stock options directly. This reflects the newly granted options under the company’s 2021 Incentive Compensation Plan, with no additional derivative holdings reported in this disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
